Medicaid Bulletin

The Centers for Medicare & Medicaid Services announced an increase in the Affordable Care Act provider enrollment application fee.

Effective with date of service Oct. 15, 2017, the NC Medicaid Program covers triamcinolone acetonide extended-release injectable suspension, for intra-articular use (Zilretta) for use in the Physician’s Drug Program (PDP) when billed with HCPCS code J3490 - Unclassified drugs.

Note: This article is being republished monthly. It was originally published in the December 2017 Medicaid Bulletin with revisions.

Effective with date of service Jan. 1, 2018, the following dental procedure codes were added for the N.C. Medicaid and Health Choice Dental Programs. These additions are a result of updates to the Current Dental Terminology (CDT) 2018 American Dental Association (ADA) Code.

Effective with date of service Oct. 23, 2017, the N.C. Medicaid and N.C. Health Choice (NCHC) programs cover meropenem and vaborbactam for injection, for intravenous use (Vabomere) for use in the Physician's Drug Program (PDP) when billed with HCPCS code J3490 - Unclassified drugs.

Note: This article was originally published in the October 2017 Medicaid Bulletin. This is the final Medicaid Bulletin publication.